{"component":{"type":17,"accent_color":7315445,"components":[{"type":10,"content":"-# WikiRNG · Roll of 10/26/2026 · by [shizzy](https://wikirng.com/u/shizzy)"},{"type":10,"content":"## [DOV-102,677](https://wikirng.com/roll/WweDTGpVMP)\n*Chemical compound*"},{"type":10,"content":">>> DOV-102,677 is a psychoactive drug being developed by Merck and is currently in clinical trials. It is a triple reuptake inhibitor (TRI), or serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI). It is the (−)-enantiomer of DOV-216,303, and its…"},{"type":14,"divider":true,"spacing":1},{"type":10,"content":"### 🟦 Obscure · 151,168 SP\n-# Top 11%"},{"type":14,"divider":true,"spacing":1},{"type":10,"content":"🟪 🫠 **Six-Seven** · Remarkable · +129,706 SP\n-# Title contains \"67\".\n🟩 📢 **Shouting** · Notable · +7,906 SP\n-# Title is all capital letters.\n🟩 🧬 **PubMed** · Notable · +3,090 SP\n-# Links to PubMed.\n🟩 ✒️ **Comma** · Notable · +1,739 SP\n-# Title has a comma.\n🟩 🔓 **Free to Read** · Notable · +1,729 SP\n-# Cites a source that is free to read.\n⬜ #️⃣ **Numbered** · Basic · +830 SP\n-# Title has a digit.\n-# +15 more badges"},{"type":14,"divider":true,"spacing":1},{"type":1,"components":[{"type":2,"style":5,"label":"View roll","url":"https://wikirng.com/roll/WweDTGpVMP"},{"type":2,"style":5,"label":"Read on Wikipedia","url":"https://en.wikipedia.org/wiki/DOV-102%2C677"}]},{"type":10,"content":"-# Article text from Wikipedia, CC BY-SA 4.0"}]}}